EPA TRI Facility · Chemicals

Glaxosmithkline LLC

Collegeville, PA · Parent: Glaxosmithkline Holdings (americas) Inc

Total releases
10.3K lbs
Chemicals reported
4
Carcinogens
1
Primary pathway
Off-site Transfers
Verify at EPA TRI →

Glaxosmithkline LLC has reported 10.3K lbs of toxic releases across 4 chemicals to the EPA Toxic Release Inventory, based on annual facility disclosures from 2019 through 2023. Of the chemicals reported, 1 is classified as carcinogen, representing 25% of the facility's chemical profile. The facility operates in the Chemicals sector. The primary release pathway is off-site transfers, accounting for 50% of total releases. All release data shown below is self-reported to the EPA under the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313.

#9,766 of 25,902 TRI facilities nationwide by total reported releases. Ranking reflects reported pounds, not toxicity or health risk.

Glaxosmithkline LLC files annual Form R disclosures to the EPA Toxics Release Inventory under EPCRA Section 313, classified under NAICS 325412 (Chemicals). Across 4 years of records spanning 2020–2023, the site has disclosed 10.3K lbs in cumulative toxic releases across 4 distinct chemicals, 1 of which (25%) carry a carcinogenic classification.

The dominant release pathway is off-site transfers at 5.2K lbs (50.3% of total volume), followed by air releases at 49.7%. Between 2020 and 2023, reported totals decreased by 67% - from 2.2K lbs to 739 lbs. The facility is operated under parent company Glaxosmithkline Holdings (americas) Inc.

TRI Form R values are self-reported estimates, not measured stack emissions, and treat every pound of reported chemical equally regardless of toxicity. Inclusion in the TRI database does not establish a health risk to nearby residents; it documents the annual reporting record that Glaxosmithkline LLC has filed with the EPA under federal community right-to-know requirements.

Quick Facts

Industry
Chemicals
NAICS Code
325412
Total Releases
10.3K lbs
Chemicals Reported
4
Latest Report Year
2023

Compare this facility

See how Glaxosmithkline LLC stacks up against nearby facilities and the typical reporter.

Total reported releases
Glaxosmithkline LLC
10.3K lbs
Max Environmental -- Yukon Facility
34.8M lbs

100% less than the comparison

Chemicals reported
Glaxosmithkline LLC
4
Max Environmental -- Yukon Facility
18

78% less than the comparison

Comparison reflects reported pounds and chemical counts, not toxicity or health risk. Averages cover facilities reporting any release.

How does this facility release toxic chemicals?

How Glaxosmithkline LLC releases toxic chemicals into the environment. Total: 10.3K lbs.

Off-site Transfers 5.2K lbs (50.3%)
Air Releases 5.1K lbs (49.7%)
View 4-Year Emissions Trend →

Emissions Trend Summary

From 2020 to 2023, total releases decreased by 67% (2.2K lbs to 739 lbs).

Reported total releases by year

Glaxosmithkline LLC - annual TRI totals

million lbs

What this shows Year-over-year reported totals. TRI figures are self-reported estimates and can swing with production levels, waste-rock handling and reporting changes, not only with emissions controls.

Source EPA Toxics Release Inventory (TRI)
Year Total Chemicals
2020 2.2K lbs 2
2021 4.7K lbs 4
2022 2.6K lbs 2
2023 739 lbs 1

Chemical Releases

Aggregated across all reporting years (2020–2023). 1 of 4 chemicals are carcinogens. Sorted by total release volume.

Chemical Total Flags
Dichloromethane 4.1K lbs Carcinogen
Methanol 3.2K lbs -
Acetonitrile 3.0K lbs -
Ethylene glycol 2 lbs -

Location

Coordinates
40.1622, -75.4789
ZIP Code
19426
EPA Facility ID
19426SMTHL1250S

About TRI Data

Data as of 2023 reporting year. Source: U.S. Environmental Protection Agency (EPA) Toxic Release Inventory.

Data comes from the EPA Toxic Release Inventory (TRI) program. Facilities that manufacture, process, or otherwise use listed toxic chemicals above threshold amounts are required to report annually to the EPA.

Release quantities are self-reported by the facility and may represent estimates rather than exact measurements. "Total releases" includes releases to air, water, land, and off-site transfers for disposal. Quantities shown here are aggregated across all available reporting years.

PlainEnviro presents this data without advocacy framing. The presence of a facility in the TRI database does not by itself indicate a health risk. For site-specific health questions, consult your local environmental or health agency.

Frequently Asked Questions

What chemicals does Glaxosmithkline LLC release?
Glaxosmithkline LLC has reported releases of 4 chemicals to the EPA Toxic Release Inventory, totaling 10.3K lbs. 1 of these (25%) are classified as carcinogens.
What industry is Glaxosmithkline LLC in?
Glaxosmithkline LLC is classified under the "Chemicals" industry (NAICS code 325412), located in Collegeville, PA.
How long has Glaxosmithkline LLC reported to the TRI?
Glaxosmithkline LLC has EPA Toxic Release Inventory data spanning 4 years, from 2020 to 2023.
How does Glaxosmithkline LLC release toxic chemicals?
The primary release pathway for Glaxosmithkline LLC is off-site transfers, accounting for 50.3% of total releases (5.2K lbs). Secondary pathway: air releases (49.7%).
Are emissions from Glaxosmithkline LLC increasing or decreasing?
From 2020 to 2023, total releases decreased by 67%, from 2.2K lbs to 739 lbs.
Is Glaxosmithkline LLC a health risk?
The presence of a facility in the TRI database does not by itself indicate a health risk. Release quantities are self-reported estimates. For site-specific health questions, consult your local environmental or health agency.
Does Glaxosmithkline LLC release carcinogens?
Yes, Glaxosmithkline LLC reports 1 chemical classified as carcinogens, representing 25% of all chemicals reported by this facility. Carcinogen classification is based on EPA and IARC assessments.

What to do with this facility's data

Use this facility profile as a starting point, then check how it compares.

  • See whether releases reported by Glaxosmithkline LLC are rising or falling over time. View trends
  • This facility ranks #9,766 of 25,902 TRI facilities nationwide by total reported releases. Ranking reflects reported pounds, not toxicity or health risk. See the full rankings
  • Check Pennsylvania's statewide profile for the full picture: total facilities, water systems, and Superfund sites. View Pennsylvania profile

TRI release totals are self-reported estimates submitted to the EPA, not independently measured stack emissions; a high rank reflects reported volume, not necessarily local health risk.

Related

Sources & how this page was built

Every figure on this page traces to public, federal-government data on Glaxosmithkline LLC. The records below are the primary sources; our methodology explains how they are joined, computed, and verified.

Retrieved and formatted by PlainEnviro Editorial. TRI release totals are self-reported estimates, not measured stack emissions.

According to the U.S. Environmental Protection Agency, the Toxics Release Inventory has required annual industrial disclosure since its creation under the Emergency Planning and Community Right-to-Know Act in October 1986, and this facility's record is drawn from PlainEnviro's database of more than 25,000 EPA-tracked facilities through the 2023 reporting year; see our methodology for full source citations and refresh cadence.